Replimune Group, Inc.

Analysis for Ticker: REPL

Replimune Group Inc claims to be a biotechnology company fighting cancer by using a modified herpes virus to kill tumor cells through its proprietary platform. The reality is a mathematical black hole that has swallowed 1.189,0$ million in capital without ever selling a single product. It functions like a reverse piggy bank where normal investors put money in and the insiders take it out through free shares and debt traps. When a company burns hundreds of millions of dollars with zero income, it stays alive by slicing its ownership into smaller and smaller pieces. This is called dilution, and it means the value of what you own is being systematically drained to pay for empty factories and executive bonuses while the company approaches total exhaustion.